Cargando…
Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus
BACKGROUND: Excessive autoantibody production characterizing systemic lupus erythematosus (SLE) occurs irrespective of the disease’s clinical status and is linked to increased lymphocyte apoptosis. Herein, we tested the hypothesis that defective DNA damage repair contributes to increased apoptosis i...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973109/ https://www.ncbi.nlm.nih.gov/pubmed/27492607 http://dx.doi.org/10.1186/s13075-016-1081-3 |
_version_ | 1782446354110349312 |
---|---|
author | Souliotis, Vassilis L. Vougas, Konstantinos Gorgoulis, Vassilis G. Sfikakis, Petros P. |
author_facet | Souliotis, Vassilis L. Vougas, Konstantinos Gorgoulis, Vassilis G. Sfikakis, Petros P. |
author_sort | Souliotis, Vassilis L. |
collection | PubMed |
description | BACKGROUND: Excessive autoantibody production characterizing systemic lupus erythematosus (SLE) occurs irrespective of the disease’s clinical status and is linked to increased lymphocyte apoptosis. Herein, we tested the hypothesis that defective DNA damage repair contributes to increased apoptosis in SLE. METHODS: We evaluated nucleotide excision repair at the N-ras locus, DNA double-strand breaks repair and apoptosis rates in peripheral blood mononuclear cells from anti-dsDNA autoantibody-positive patients (six with quiescent disease and six with proliferative nephritis) and matched healthy controls following ex vivo treatment with melphalan. Chromatin organization and expression levels of DNA repair- and apoptosis-associated genes were also studied in quiescent SLE. RESULTS: Defective nucleotide excision repair and DNA double-strand breaks repair were found in SLE, with lupus nephritis patients showing higher DNA damage levels than those with quiescent disease. Melphalan-induced apoptosis rates were higher in SLE than control cells and correlated inversely with DNA repair efficiency. Chromatin at the N-ras locus was more condensed in SLE than controls, while treatment with the histone deacetylase inhibitor vorinostat resulted in hyperacetylation of histone H4, chromatin decondensation, amelioration of DNA repair efficiency and decreased apoptosis. Accordingly, genes involved in DNA damage repair and signaling pathways, such as DDB1, ERCC2, XPA, XPC, MRE11A, RAD50, PARP1, MLH1, MLH3, and ATM were significantly underexpressed in SLE versus controls, whereas PPP1R15A, BARD1 and BBC3 genes implicated in apoptosis were significantly overexpressed. CONCLUSIONS: Epigenetically regulated functional abnormalities of DNA repair machinery occur in SLE, regardless of clinical disease activity, and may promote lymphocyte apoptosis. Approaches to correct these abnormalities may be of therapeutic value in SLE. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-016-1081-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4973109 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49731092016-08-05 Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus Souliotis, Vassilis L. Vougas, Konstantinos Gorgoulis, Vassilis G. Sfikakis, Petros P. Arthritis Res Ther Research Article BACKGROUND: Excessive autoantibody production characterizing systemic lupus erythematosus (SLE) occurs irrespective of the disease’s clinical status and is linked to increased lymphocyte apoptosis. Herein, we tested the hypothesis that defective DNA damage repair contributes to increased apoptosis in SLE. METHODS: We evaluated nucleotide excision repair at the N-ras locus, DNA double-strand breaks repair and apoptosis rates in peripheral blood mononuclear cells from anti-dsDNA autoantibody-positive patients (six with quiescent disease and six with proliferative nephritis) and matched healthy controls following ex vivo treatment with melphalan. Chromatin organization and expression levels of DNA repair- and apoptosis-associated genes were also studied in quiescent SLE. RESULTS: Defective nucleotide excision repair and DNA double-strand breaks repair were found in SLE, with lupus nephritis patients showing higher DNA damage levels than those with quiescent disease. Melphalan-induced apoptosis rates were higher in SLE than control cells and correlated inversely with DNA repair efficiency. Chromatin at the N-ras locus was more condensed in SLE than controls, while treatment with the histone deacetylase inhibitor vorinostat resulted in hyperacetylation of histone H4, chromatin decondensation, amelioration of DNA repair efficiency and decreased apoptosis. Accordingly, genes involved in DNA damage repair and signaling pathways, such as DDB1, ERCC2, XPA, XPC, MRE11A, RAD50, PARP1, MLH1, MLH3, and ATM were significantly underexpressed in SLE versus controls, whereas PPP1R15A, BARD1 and BBC3 genes implicated in apoptosis were significantly overexpressed. CONCLUSIONS: Epigenetically regulated functional abnormalities of DNA repair machinery occur in SLE, regardless of clinical disease activity, and may promote lymphocyte apoptosis. Approaches to correct these abnormalities may be of therapeutic value in SLE. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-016-1081-3) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-04 2016 /pmc/articles/PMC4973109/ /pubmed/27492607 http://dx.doi.org/10.1186/s13075-016-1081-3 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Souliotis, Vassilis L. Vougas, Konstantinos Gorgoulis, Vassilis G. Sfikakis, Petros P. Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus |
title | Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus |
title_full | Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus |
title_fullStr | Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus |
title_full_unstemmed | Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus |
title_short | Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus |
title_sort | defective dna repair and chromatin organization in patients with quiescent systemic lupus erythematosus |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973109/ https://www.ncbi.nlm.nih.gov/pubmed/27492607 http://dx.doi.org/10.1186/s13075-016-1081-3 |
work_keys_str_mv | AT souliotisvassilisl defectivednarepairandchromatinorganizationinpatientswithquiescentsystemiclupuserythematosus AT vougaskonstantinos defectivednarepairandchromatinorganizationinpatientswithquiescentsystemiclupuserythematosus AT gorgoulisvassilisg defectivednarepairandchromatinorganizationinpatientswithquiescentsystemiclupuserythematosus AT sfikakispetrosp defectivednarepairandchromatinorganizationinpatientswithquiescentsystemiclupuserythematosus |